HDAC6 and plasma cell myeloma: Although As2O3 has been extensively studied as potential anti-myeloma treatment, the precise functions of As2O3 in the myeloma cells remain to be defined; especially whether As2O3 could affect activity in HDAC6-Hsp90-IKKα-NFκB signaling axis.